Candel Therapeutics, Inc. Common Stock CADL
$8.17
+4.88%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-10-02 | View → |
| 4 | 4 | 2026-10-02 | View → |
| 4 | 4 | 2026-10-02 | View → |
| 4 | 4 | 2026-09-11 | View → |
| 4 | 4 | 2026-09-10 | View → |
| 8-K | 8-K | 2026-09-10 | View → |
| 8-K | 8-K | 2026-09-09 | View → |
| 4 | 4 | 2026-08-19 | View → |
| 10-Q | 10-Q | 2026-08-13 | View → |
| 8-K | 8-K | 2026-08-13 | View → |
| 4 | 4 | 2026-07-08 | View → |
| 4 | 4 | 2026-07-01 | View → |
| 4 | 4 | 2026-07-01 | View → |
| 4 | 4 | 2026-07-01 | View → |
| 4 | 4 | 2026-07-01 | View → |
| 4 | 4 | 2026-07-01 | View → |
| 4 | 4 | 2026-06-24 | View → |
| 4 | 4 | 2026-06-24 | View → |
| 4 | 4 | 2026-06-24 | View → |
| 4 | 4 | 2026-06-24 | View → |
| 4 | 4 | 2026-06-24 | View → |
| 4 | 4 | 2026-06-24 | View → |
| 4 | 4 | 2026-06-24 | View → |
| 4 | 4 | 2026-06-24 | View → |
| 4 | 4 | 2026-06-24 | View → |
| 8-K | 8-K | 2026-06-24 | View → |
| 8-K | 8-K | 2026-06-16 | View → |
| 8-K | 8-K | 2026-05-15 | View → |
| 10-Q | 10-Q | 2026-05-14 | View → |
| 8-K | 8-K | 2026-05-14 | View → |
| DEF 14A | DEF 14A | 2026-04-29 | View → |
| 4 | 4 | 2026-04-02 | View → |
| 4 | 4 | 2026-04-02 | View → |
| 4 | 4 | 2026-04-02 | View → |
| 10-K | 10-K | 2026-03-12 | View → |
| 8-K | 8-K | 2026-03-12 | View → |
| 4 | 4 | 2026-02-26 | View → |
| 8-K | 8-K | 2026-02-23 | View → |
| 424B5 | 424B5 | 2026-02-20 | View → |
| 424B5 | 424B5 | 2026-02-19 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $8.17
- Market Cap
- $596.08 million
- 52-Week Range
- $4.35 – $14.00
- Average Volume
- 1.04 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.